WSR 20-15-035
PREPROPOSAL STATEMENT OF INQUIRY
HEALTH CARE AUTHORITY
[Filed July 7, 2020, 4:25 p.m.]
Subject of Possible Rule Making: WAC 182-530-3000 When the medicaid agency requires authorization, 182-530-3100 How the medicaid agency determines when a drug requires authorization, 182-530-3200 The medicaid agency's authorization process, 182-530-4000 Drug use review (DUR) board, 182-530-4100 Medicaid preferred drug list (medicaid PDL); and other related rules as appropriate.
Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: The agency is amending these rules to reflect necessary changes resulting from the implementation of the apple health preferred drug list. During the course of this review, the agency may identify additional related changes that are required in order to improve clarity or update policy.
Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Not applicable.
Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.
Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Melinda Froud (Rulemaking Questions), P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-1408, fax 360-586-9727, telecommunication[s] relay services (TRS) 711, email Melinda.froud@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking; or Charles Agte (Program Questions), P.O. Box 45502, Olympia, WA 98504-5502, phone 360-725-1301, fax 360-725-2141, TRS 711, email Charles.agte@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking.
July 7, 2020
Wendy Barcus
Rules Coordinator